Deciphera Pharma shares are trading higher after the company announced its study of patients with TGCT met its primary and secondary endpoint.

Deciphera Pharmaceuticals +1.97%

Deciphera Pharmaceuticals

DCPH

16.06

+1.97%

Deciphera Pharma shares are trading higher after the company announced its study of patients with TGCT met its primary and secondary endpoint.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via